Page 87 - Memoria FEHH - SEHH 2017

MEMORIA ANUAL 2017
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
• Barata A, Martino R, Gich I, García-Cadenas I, Abella E, Barba P, Briones J, Brunet S, Esquirol A, García-Pallarols F, Garrido A, Granell M, Martínez J, Mensa I, Novelli S, Sánchez-González B, Valcárcel D, Sierra J. Do Patients and Physicians Agree When They Assess Quality of Life? Biol Blood Marrow Transplant. 2017;23(6):1005-10.
• García-Cadenas I, Rivera I, Martino R, Esquirol A, Barba P, Novelli S, Orti G, Briones J, Brunet S, Valcárcel D, Sierra J.
Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease. Bone Marrow Transplant. 2017 Jan;52(1):107-13.
• Piñana JL, Pérez-Pitarch A, García-Cadenas I, Barba P, Hernández-Boluda JC, Esquirol A, Fox ML, Terol MJ, Queraltó JM, Vima J, Valcárcel D, Ferriols-Lisart R, Sierra J, Solano C, Martino R. A Time-to-Event Model for Acute Kidney In- jury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis. Biol Blood Marrow Transplant. 2017 Jul;23(7):1177-85.
• Piñana JL, Hernández-Boluda JC, Calabuig M, Ballester I, Marín M, Madrid S, Teruel A, Terol MJ, Navarro D, Solano C. A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: a pilot study. Transpl Infect Dis. 2017 Aug;19(4).
• Piñana JL, Madrid S, Pérez A, Hernández-Boluda JC, Giménez E, Terol MJ, Calabuig M, Navarro D, Solano C. Epidemi- ologic and Clinical Characteristics of Coronavirus and Bocavirus Respiratory Infections after Allogeneic Stem Cell Transplantation: A Prospective Single-Center Study. Biol Blood Marrow Transplant. 2018 Mar;24(3):563-70.
• González-Vicent M, Molina B, Deltoro N, Sevilla J, Vicario JL, Castillo A, Ramírez M, Díaz MÁ. Donor age matters in T-cell depleted haploidentical hematopoietic stem cell transplantation in pediatric patients: Faster immune reconstitution using younger donors. Leuk Res. 2017 Jun;57:60-4.
• Esquirol A, Pascual MJ, Ortiz M, Piñana JL, Ferra C, García Cadenas I, Vilades I, Brunet S, Martino R, Sierra J. Single- agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies. Bone Marrow Transplant. 2017 Sep;52(9):1273-9.
• Arteche-López A, Kreutzman A, Alegre A, Sanz Martín P, Aguado B, González-Pardo M, Espiño M, Villar LM, García Belmonte D, de la Cámara R, Muñoz-Calleja C. Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implica- tion. Bone Marrow Transplant. 2017 Jun;52(6):832-8.
• Espiño M, Arteche-López A, Medina S, Muñoz-Calleja C, Blanchard MJ, Alegre A, López-Jiménez FJ, Villar LM. In- volved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients. Bone Marrow Transplant. 2017 Aug;52(8):1206-7.
• Fernández L, Metais JY, Escudero A, Vela M, Valentín J, Vallcorba I, Leivas A, Torres J, Valeri A, Patiño-García A, Mar- tínez J, Leung W, Pérez-Martínez A. Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells. Clin Cancer Res. 2017 Oct 1;23(19):5824-35.
GRUPO ESPAÑOL DE TRASPLANTE HEMATOPOYÉTICO (GETH)
87